Evofem Holdings, Inc. Announces Successful Completion of Pre-IND Meeting for Amphora
11. Januar 2016 08:25 ET
|
Evofem
SAN DIEGO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Evofem, a biotechnology company focused on the development and commercialization of women's health products, announced today that it met with...
Evofem, Inc. Expands Management Team
06. Januar 2016 09:11 ET
|
Evofem
SAN DIEGO, CALIF., Jan. 6, 2016 (GLOBE NEWSWIRE) -- Evofem, Inc. announced today that Brandi Howard has been named Vice President of Global Medical Affairs and Nicole Beckstrand has been named Vice...
Evofem, Inc. Appoints Sandra Matsumoto as Vice President of Global Regulatory Affairs
16. Dezember 2015 14:55 ET
|
Evofem
SAN DIEGO, Dec. 16, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announces that Sandra Matsumoto has been named Vice President of Global Regulatory Affairs effective immediately. In this role, Dr. Matsumoto...
Evofem, Inc. Announces FDA Acceptance of New Drug Application for Amphora(TM) as a Contraceptive
22. September 2015 08:07 ET
|
Evofem
SAN DIEGO, Sept. 22, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. today announced that a New Drug Application for Amphora has been accepted for filing by the United States Food and Drug Administration (FDA)....
Evofem, Inc. Appoints Sandra Orta as Vice President of Global Sales and Marketing
17. August 2015 09:07 ET
|
Evofem
SAN DIEGO, Aug. 17, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announces that Sandra Orta has been named Vice President of Global Marketing & Strategy effective immediately. In this role, Ms. Orta will...
Evofem, Inc. Appoints Russell Barrans as Vice President of Sales and Marketing North America
08. Juli 2015 09:05 ET
|
Evofem
SAN DIEGO, July 8, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announces that Russell Barrans has been named Vice President of Sales and Marketing for North America effective immediately. In this role, Mr....
Evofem, Inc. Submits New Drug Application to U.S. FDA for Amphora(TM) as a Contraceptive
06. Juli 2015 09:03 ET
|
Evofem
SAN DIEGO, CALIF., July 6, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of...
Evofem, Inc. Appoints Dr. Kelly Culwell as Chief Medical Officer
01. Juli 2015 12:06 ET
|
Evofem
SAN DIEGO, July 1, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announces that Dr. Kelly Culwell has been named Chief Medical Officer, effective immediately. In this role, Dr. Culwell will provide medical...
Evofem, Inc. Appoints Dr. David Friend as Senior Vice President of Product Development
01. April 2015 09:08 ET
|
Evofem
SAN DIEGO, April 1, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announces that Dr. David Friend has been named Senior Vice President of Product Development, effective immediately.
In this role, Dr. Friend...
Evofem, Inc. Appoints Louis Villalba as Chief Business Officer
20. Februar 2015 09:10 ET
|
Evofem
SAN DIEGO, Feb. 20, 2015 (GLOBE NEWSWIRE) -- Evofem, Inc. announces that Louis Villalba has been named Chief Business Officer (CBO), effective immediately. Mr. Villalba comes to Evofem with years of...